Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary

By: via Benzinga
Akero Therapeutics (NASDAQ: AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of ...
Related Stocks:
Akero Therapeutics Inc Akouos Inc Atyr Pharma Inc Cidara Thera Conformis Inc CS Genfit S.A. ADR Lyra Therapeutics Inc Merck & Co Oramed Pharma Syros Pharmaceuticals Vaxxinity, Inc. - Class A Common Stock
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.